Additional file 1: Table S1. of Cardiovascular risk in patients with alpha-1-antitrypsin deficiency

Analysis of lung density by CT (available for 379 patients). (f) n = 3 missings, (g) n = 89 missings, *panlobular emphysema, PLE; centrilobular emphysema, CLE. Table E2. Multivariate linear regression model with TLCO %pred. as dependent variable. AATD refers to the presence of AATD versus COPD. Figure S1. Patients with AATD revealed a reduced TLCO %pred at similar levels of ITGV %pred. (A, B) or BMI (B, D) for both female and male patients after adjustment for FEV1, sex, BMI, packyears, and age (AATD - dotted line, COPD - straight line). Table S3. Results (Odds Ratio [95% confidence interval] and p-value) of multivariable logistic regression analyses for different comorbidities as dependent variable. (DOCX 265 kb

Results of path analysis.

<p>Final path analysis model comprising three layers: risk factors, comorbidities and lung function parameters. The structure only contains relationships which turned out to be statistically significant (p<0.05 each). Error terms of dependent variables have been omitted for the sake of clarity. Correlations between the independent variables are indicated by arched arrows.</p

Results of the final path analysis model.

<p>Results of the final path analysis model.</p

Additional file 1 of Alpha-1-antitrypsin-deficiency is associated with lower cardiovascular risk: an approach based on federated learning

Supplementary Material 1: Figure 1. Flow chart demonstrating the number of AATD and Non-AATD patients at each research database and the respective recording perio